Where should I publish my paper?
Paste your title, abstract or keywords. The finder matches them to research topics and suggests ranked journals that publish most on those topics.
Journals for “Prostate Cancer Diagnosis and Treatment”
Suggested journals
Topic match is relative to the best match in this search (100% = best). Fees are shown only where DOAJ records them.
| # | Journal | Topic match | ITS Journal Score | Global rank | Papers 2021–2025 | Open access | Fee (APC) |
|---|---|---|---|---|---|---|---|
| 1 | Prostate Cancer and Prostatic Diseases Springer Nature · United Kingdom | 98% | 80.0 | #2,152 | 761 | 55% | Not recorded |
| 2 | Prostate International Elsevier BV · South Korea · DOAJ | 100% | 62.4 | #11,360 | 188 | 100% | US$1,800 |
| 3 | European Urology Oncology Elsevier BV · The Netherlands | 71% | 78.1 | #2,846 | 843 | 46% | Not recorded |
| 4 | The Prostate Wiley · United States | 69% | 76.0 | #3,689 | 1,032 | 49% | Not recorded |
| 5 | British Journal of Urology Wiley · United Kingdom | 59% | 77.6 | #3,034 | 1,787 | 56% | Not recorded |
| 6 | Prostate Cancer Hindawi Publishing Corporation · United Kingdom · DOAJ | 68% | 52.2 | #17,961 | 75 | 100% | US$1,100 |
| 7 | European Urology Elsevier BV · Switzerland | 53% | 77.1 | #3,223 | 9,361 | 12% | Not recorded |
| 8 | European Urology Focus Elsevier BV · The Netherlands | 51% | 76.7 | #3,428 | 1,072 | 31% | Not recorded |
| 9 | BJUI Compass Wiley · United States · DOAJ | 55% | 61.4 | #12,032 | 598 | 100% | US$3,050 |
| 10 | Nature Reviews Urology Nature Portfolio · United Kingdom | 43% | 81.4 | #1,694 | 696 | 19% | Not recorded |
| 11 | Urologic Oncology Seminars and Original Investigations Elsevier BV · United States | 47% | 71.5 | #5,971 | 2,097 | 19% | Not recorded |
| 12 | Scandinavian Journal of Urology Informa · United Kingdom · DOAJ | 47% | 64.6 | #10,040 | 282 | 100% | Not recorded |
| 13 | European Urology Open Science Elsevier BV · The Netherlands · DOAJ | 49% | 60.6 | #12,584 | 6,035 | 100% | US$2,500 |
| 14 | World Journal of Urology Springer Science+Business Media · Germany | 39% | 78.7 | #2,610 | 2,601 | 36% | Not recorded |
| 15 | Clinical Genitourinary Cancer Elsevier BV · United States | 42% | 72.0 | #5,708 | 968 | 38% | Not recorded |
| 16 | The Journal of Urology Lippincott Williams & Wilkins · United States | 42% | 68.3 | #7,784 | 16,295 | 4% | Not recorded |
| 17 | Minerva Urology and Nephrology Edizioni Minerva Medica · Italy | 40% | 70.2 | #6,686 | 669 | 16% | Not recorded |
| 18 | Journal of Contemporary Brachytherapy Termedia Publishing House · Poland · DOAJ | 45% | 59.1 | #13,441 | 332 | 100% | 1,500 PLN |
| 19 | International Journal of Urology Wiley · Japan | 36% | 72.3 | #5,544 | 1,611 | 39% | Not recorded |
| 20 | Canadian Urological Association Journal Canadian Urological Association Journal · Canada | 41% | 62.8 | #11,135 | 980 | 100% | Not recorded |
| 21 | Asian journal of urology Elsevier BV · Singapore · DOAJ | 39% | 65.3 | #9,618 | 393 | 100% | Not recorded |
| 22 | Korean journal of urology The Korean Urological Association · South Korea · DOAJ | 37% | 69.9 | #6,847 | 393 | 100% | Not recorded |
| 23 | Urology Practice Lippincott Williams & Wilkins · United States | 43% | 57.0 | #14,805 | 1,111 | 9% | Not recorded |
| 24 | Bulletin of Urooncology Galenos Yayinevi · Türkiye · DOAJ | 52% | 40.3 | #28,016 | 161 | 100% | Not recorded |
| 25 | Current Urology Reports Springer Science+Business Media · United States | 35% | 71.2 | #6,087 | 295 | 27% | Not recorded |
| 26 | Current Opinion in Urology Lippincott Williams & Wilkins · United States | 34% | 71.0 | #6,218 | 483 | 14% | Not recorded |
| 27 | The French Journal of Urology Elsevier BV · France | 38% | 63.3 | #10,786 | 979 | 35% | Not recorded |
| 28 | Brachytherapy Elsevier BV · United States | 39% | 61.9 | #11,702 | 1,697 | 13% | Not recorded |
| 29 | BMC Urology BioMed Central · United Kingdom · DOAJ | 33% | 72.2 | #5,571 | 1,238 | 100% | 2,690 EUR |
| 30 | International braz j urol Sociedade Brasileira de Urologia · Brazil · DOAJ | 32% | 73.1 | #5,074 | 615 | 100% | Not recorded |
Before you submit
Use this list as a shortlist, not a decision. For each journal, read its aims and scope and a few recent articles, check its peer-review and fee policy on its own website, and confirm any indexing (Scopus, Web of Science, PubMed) with the indexer itself. Be careful with journals that promise very fast acceptance or that contact you by email asking for papers.
How the ITS Journal Score works
One formula applies to every ranked journal, using open data from OpenAlex: 45% citation impact, 35% h-index and 20% size (papers published 2021–2025). Citation impact is the smaller of the journal's two-year mean citedness and its five-year citations per paper, so a journal whose output collapsed cannot jump to the top on old citations. Each part is half a percentile and half a log-scaled value, so the very top is still separated. Growth and open-access share are shown separately and are not part of the score.
A journal is ranked only if it published at least 50 papers in 2021–2025 and was active in at least five of the last six years. Field rankings compare a journal only with journals in the same field; the field is the OpenAlex field with most of the journal's recent papers, or "Multidisciplinary" when no field has 30% of them.
What this is not: the ITS Journal Score is not a Journal Impact Factor, CiteScore or SJR, and this site does not say whether a journal is indexed in Scopus, Web of Science or PubMed. Always confirm aims and scope, indexing, peer review and fees on the journal's own website before you submit.